Cargando…
BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy?
Autores principales: | Roychoudhuri, Rahul, Hirahara, Kiyoshi, Mousavi, Kambiz, Clever, David, Bonelli, Michael, Klebanoff, Christopher, Sartorelli, Vittorio, Kanno, Yuka, Gattinoni, Luca, Wang, Ena, Liu, Hui, Marincola, Franco, Kazuhiko, Igarashi, O’Shea, John, Restifo, Nicholas P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991066/ http://dx.doi.org/10.1186/2051-1426-1-S1-O14 |
Ejemplares similares
-
Bach2 represses effector programmes to stabilize T(reg)-mediated immune homeostasis
por: Roychoudhuri, Rahul, et al.
Publicado: (2013) -
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers
por: Roychoudhuri, Rahul, et al.
Publicado: (2016) -
EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion
por: Yang, Xiang-Ping, et al.
Publicado: (2015) -
Fas expression in memory CD8+ T cell subsets augments cellular differentiation and effector function
por: Yamamoto, Tori, et al.
Publicado: (2015) -
Inhibition of the T cell oxygen sensing machinery promotes anti-tumor efficacy
por: Clever, David, et al.
Publicado: (2015)